glp-1 small molecule agonist Aleniglipron: An Oral, GLP-1R Fast-Follower from Structure Therapeutics A novel approach to exploit
Description
[DOI] [PubMed] [Google Scholar] 76.Zhou ZD, et al
Wang, L., Wang, W., Kaelber, D
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Elkin J, et al
Several such studies are ongoing or planned, including those exploring weight management and metabolic support during therapy
2013;5 doi: 10.1126/scitranslmed.3007218
Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database
